Furthermore, we discovered that a HIF-1α target gene—the glycolytic enzyme Phosphofructokinase, Platelet (PFKP, PFK1)—functions as a central mediator of HBO’s effects in hypoxic NSCLC cells. Here, HIF1A is linked to non-small cell lung carcinoma.